| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Clinical and Vaccine Immunology, February 2008, p. 376-378, Vol. 15, No. 2
1071-412X/08/$08.00+0 doi:10.1128/CVI.00285-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Life and Environmental Sciences,1 High Technology Research Center, Chiba Institute of Technology, 2-17-1 Tsudanuma, Narashino, Chiba 275-0016, Japan,2 Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana Chuo-ku, Chiba 260-8670, Japan3
Received 9 July 2007/ Returned for modification 15 October 2007/ Accepted 19 November 2007
The baculovirus Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) has been studied as a gene therapy vector. Here, we demonstrated that AcMNPV induces antitumor acquired immunity. These results suggest that AcMNPV has the potential to be an efficient virus or tumor therapy agent which induces innate and acquired immunity.
Published ahead of print on 5 December 2007.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»